Our Clinical Trial Unit consists of a specialized, multidisciplinary team that offers innovative therapies for pediatric cancer patients. The team provides these children and adolescents with access to new treatment methods under strictly controlled clinical conditions. The Clinical Trial Unit is led by Cornelis van Tilburg, MD, PhD, and collaborates closely with other pediatric oncology centers. This collaboration occurs both internationally within the ITCC network and regionally within the GPOH Phase I/II Network SELECT Southwest, which is coordinated at KiTZ. Together with experts from twelve other centers, a network for early clinical studies has been established to facilitate patient access to novel medications and improve patient recruitment for early clinical studies in Southwest Germany and beyond.
Our team is not only responsible for treating young patients in clinical trials but also for providing consultation and second opinion services. Additionally, KiTZ itself develops and coordinates clinical trials through the Trial Development Group and Study Management Group. With this individualized approach, our research unit plays a leading role in Europe.
